Type 1 Diabetes

Head to Head Studies

Admelog® (insulin lispro 100 units/mL)  

Head to Head Studies

Trurapi®▼ (insulin aspart 100 units/mL)  

Toujeo (insulin glargine 300 Units/mL) Versus insulin degludec 100 units/mL in T1DM

Benefits of switching to Toujeo (insulin glargine 300 Units/mL) through patient case studies and patient reported outcomes

Explore Toujeo (insulin glargine 300 Units/mL) data from the pivotal randomised controlled clinical trials

T1 Evidence in Children

T1 Edition Junior Study

T1DM - Meta-Analysis

T1 Evidence in Adults

InRange Study

SPARTA study

Toujeo (insulin glargine 300 Units/mL) Versus insulin glargine 100 units/mL in T1DM

Toujeo (insulin glargine 300 Units/mL) Versus insulin degludec 100 units/mL in T1DM